Gili Kenet Selected Research

Minor Surgical Procedures (Minor Surgery)

11/2019	Emicizumab prophylaxis among infants and toddlers with severe hemophilia A and inhibitors-a single-center cohort.
12/2018	Alternative treatment options for pediatric hemophilia B patients with high-responding inhibitors: A thrombin generation-guided study.
1/2017	Combination of hemostatic therapies for treatment of patients with hemophilia A and inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gili Kenet Research Topics

Disease

44	Hemorrhage 01/2022 - 12/2002
33	Hemophilia A (Haemophilia) 05/2022 - 01/2006
18	Thrombosis (Thrombus) 04/2021 - 07/2008
14	Thrombophilia 01/2022 - 10/2004
12	Venous Thromboembolism 01/2022 - 09/2012
7	Hemophilia B (Haemophilia B) 04/2020 - 09/2016
4	Wounds and Injuries (Trauma) 01/2022 - 12/2002
4	Thrombocytopenia (Thrombopenia) 01/2022 - 03/2011
4	Stroke (Strokes) 01/2013 - 01/2005
4	Thromboembolism 10/2011 - 12/2009
3	Venous Thrombosis (Deep-Vein Thrombosis) 10/2020 - 10/2011
3	Neoplasms (Cancer) 01/2020 - 01/2006
3	Thrombasthenia (Glanzmann Thrombasthenia) 01/2019 - 09/2018
3	Protein S Deficiency (Deficiency, Protein S) 01/2013 - 04/2010
3	Protein C Deficiency 04/2010 - 01/2009
3	Ischemic Stroke 12/2009 - 01/2007
2	von Willebrand Diseases (von Willebrand's Disease) 01/2022 - 01/2021
2	Pulmonary Embolism 01/2022 - 11/2016
2	Metrorrhagia (Spotting) 09/2021 - 01/2020
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 12/2017
2	Choroidal Neovascularization 01/2021 - 01/2019
2	Hemarthrosis 01/2021 - 01/2017
2	Neonatal Alloimmune Thrombocytopenia 12/2018 - 08/2017
2	Inflammation (Inflammations) 01/2017 - 05/2012
2	Infections 03/2015 - 07/2008
2	Necrosis 01/2015 - 02/2009
2	Disseminated Intravascular Coagulation 01/2015 - 07/2008
2	Sepsis (Septicemia) 01/2015 - 12/2002
1	Type 3 von Willebrand Disease 01/2021
1	Joint Diseases (Joint Disease) 01/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2020
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2019
1	Congenital Disorders of Glycosylation 09/2019
1	Seizures (Absence Seizure) 09/2019
1	Megalencephaly 09/2019

Drug/Important Bio-Agent (IBA)

13	Factor VIII (Coagulation Factor VIII)IBA 05/2022 - 01/2013
13	Hemostatics (Antihemorrhagics)IBA 01/2022 - 12/2002
12	Protein CIBA 01/2021 - 01/2009
10	Thrombin FDA Link 05/2022 - 07/2008
9	emicizumabIBA 05/2022 - 11/2019
9	recombinant FVIIa (rFVIIa)FDA Link 01/2020 - 12/2002
9	AntithrombinsIBA 01/2020 - 01/2009
8	Prothrombin (Factor II)IBA 02/2021 - 01/2005
8	Factor VIIa (Activated Factor VII)IBA 01/2020 - 12/2002
7	AntibodiesIBA 05/2022 - 04/2011
7	Protein SIBA 01/2018 - 01/2009
6	Blood Coagulation Factors (Coagulation Factor)IBA 05/2022 - 07/2008
6	AnticoagulantsIBA 01/2021 - 09/2012
6	RivaroxabanIBA 10/2020 - 12/2016
6	Factor IX (Coagulation Factor IX)FDA LinkGeneric 04/2020 - 09/2016
6	factor V LeidenIBA 01/2015 - 01/2005
5	Vitamin K FDA Link 01/2022 - 07/2008
5	Antiphospholipid AntibodiesIBA 10/2017 - 01/2009
3	Fibrinogen (Factor I)FDA Link 01/2022 - 05/2011
3	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2006
3	AlbuminsIBA 04/2020 - 09/2016
3	Heparin (Liquaemin)FDA LinkGeneric 01/2020 - 06/2017
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2019 - 06/2010
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2022 - 10/2007
2	Blood Group Antigens (Blood Groups)IBA 01/2022 - 02/2021
2	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 05/2021 - 01/2020
2	BAY 94-9027IBA 05/2021 - 05/2020
2	Inosine Triphosphate (ITP)IBA 01/2021 - 12/2017
2	Recombinant Fusion ProteinsIBA 04/2020 - 09/2016
2	von Willebrand FactorIBA 09/2019 - 01/2013
2	Factor V (Coagulation Factor V)IBA 01/2018 - 04/2014
2	anti-inhibitor coagulant complexIBA 01/2018 - 01/2017
2	Surface-Active Agents (Surfactants)IBA 01/2018 - 11/2013
2	ChitosanIBA 05/2017 - 03/2014
2	vinyltriethoxysilane (VTES)IBA 11/2016 - 01/2006
2	SteroidsIBA 05/2012 - 06/2010
2	ORALIT (ORS)IBA 10/2011 - 04/2010
2	Asparaginase (Elspar)FDA Link 06/2010 - 03/2009
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2009 - 01/2005
1	Monoclonal AntibodiesIBA 05/2022
1	Pharmaceutical PreparationsIBA 05/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	marstacimabIBA 01/2022
1	Cardiolipins (Cardiolipin)IBA 01/2022
1	Tranexamic Acid (AMCA)FDA Link 01/2022
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2022
1	A-factor (Streptomyces)IBA 09/2021
1	Dabigatran FDA Link 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	recombinant factor VIII SQIBA 05/2020
1	human F8 protein FDA Link 01/2020
1	SuspensionsIBA 01/2020
1	TabletsIBA 01/2020
1	Factor IXa (Coagulation Factor IXa)IBA 11/2019
1	Factor X (Stuart Factor)IBA 11/2019
1	Fondaparinux (Arixtra)FDA Link 10/2019

Therapy/Procedure

26	Therapeutics 05/2022 - 10/2003
6	Catheters 04/2021 - 03/2015
4	Central Venous Catheters 10/2020 - 03/2015
3	Minor Surgical Procedures (Minor Surgery) 11/2019 - 01/2017
3	Platelet Transfusion (Blood Platelet Transfusions) 01/2019 - 01/2018
2	Operative Surgical Procedures 01/2022 - 09/2018
2	Injections 04/2020 - 09/2016
1	Cesarean Section (Caesarean Section) 10/2019